About 3 results found for searched term "Bis-T-23" (0.242 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M41624 | Bis-T-23 | Dynamin |
| Bis-T-23 (AG1717), tyrphostin derivative, is an HIV-I integrase inhibitor. | ||
| M24780 | Flotetuzumab | Others |
| MGD006 S80880 | ||
| Flotetuzumab (MGD006; S80880) is an investigational CD123/CD3 bispecific dual-affinity retargeting antibody (DART) molecule. Flotetuzumab reactivates T cells by simultaneously binding to CD123 in target cells and CD3 in effector T cells, leading to T-cell-mediated cytotoxicity in target cells. Flotetuzumab shows inhibitory effect on a mouse model of patient-derived xenograft (PDX) in acute myeloid leukemia (AML). | ||
| M24942 | Vibecotamab | Others |
| XmAb14045 | ||
| Vibecotamab (XmAb14045) is a potent bispecific antibody against CD123 and CD3 that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
